BioAdvance — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Midway PharmaceuticalsApr 2017
BiotechSpring House, US
Harry Arader(Director)Rifat Pamukcu(Executive Officer, Director)
OpsidioSep 2017
BiotechBryn Mawr, US
Martin D. Phillips(Executive Officer, Director)Nicholas W. Lukacs(Director)Frank Marcoux(Director)Alan E. Casnoff(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.